Skip to main content

ADVERTISEMENT

Jennifer Ford

Clinical Insights
05/30/2016
Editor's note: View related video.Robert Abraham, MD, FSIR, is an interventional radiologist with Dalhousie University Department of Diagnostic Imaging in Halifax, Nova Scotia. He and his colleagues undertook a study of imageable embolic...
Editor's note: View related video.Robert Abraham, MD, FSIR, is an interventional radiologist with Dalhousie University Department of Diagnostic Imaging in Halifax, Nova Scotia. He and his colleagues undertook a study of imageable embolic...
Editor's note: View related...
05/30/2016
IO Learning
Clinical Insights
02/27/2014
IO360 sat down with clinical editor Govindarajan Narayanan, MD, of the University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center (SCCC) to discuss the use of irreversible electroporation (IRE) at SCCC.Q: Please...
IO360 sat down with clinical editor Govindarajan Narayanan, MD, of the University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center (SCCC) to discuss the use of irreversible electroporation (IRE) at SCCC.Q: Please...
IO360 sat down with clinical...
02/27/2014
IO Learning
Clinical Insights
01/12/2016
Afshin Gangi, MD, PhD, is professor of interventional radiology and chief of interventional radiology at the University Hospital Strasbourg, in Strasbourg, France. He is also a professor at King’s College in London, and a member of the...
Afshin Gangi, MD, PhD, is professor of interventional radiology and chief of interventional radiology at the University Hospital Strasbourg, in Strasbourg, France. He is also a professor at King’s College in London, and a member of the...
Afshin Gangi, MD, PhD, is...
01/12/2016
IO Learning
Interview
05/20/2015
In April, the first training center for vascular clinical trials opened in Boston.
In April, the first training center for vascular clinical trials opened in Boston.
In April, the first training...
05/20/2015
Vascular Disease Management
Clinical Insights
12/30/2014
At the 2014 Synergy interventional oncology meeting in Miami, Florida, Interventional Oncology 360 spoke with editorial board member Jose Hugo Mendez Luz, MD, from the National Cancer Institute (INCA) in Rio de Janiero, Brazil, about the...
At the 2014 Synergy interventional oncology meeting in Miami, Florida, Interventional Oncology 360 spoke with editorial board member Jose Hugo Mendez Luz, MD, from the National Cancer Institute (INCA) in Rio de Janiero, Brazil, about the...
At the 2014 Synergy...
12/30/2014
IO Learning
Clinical Insights
05/22/2016
Franz Edward Boas, MD, is an interventional radiologist at Memorial Sloan Kettering Cancer Center. Dr. Boas and his colleagues have developed a tool for planning cryoablation procedures, and he presented details about the tool at the 2016...
Franz Edward Boas, MD, is an interventional radiologist at Memorial Sloan Kettering Cancer Center. Dr. Boas and his colleagues have developed a tool for planning cryoablation procedures, and he presented details about the tool at the 2016...
Franz Edward Boas, MD, is an...
05/22/2016
IO Learning
Clinical Insights
12/18/2013
Six years ago, at the conclusion of the International Symposium on Endovascular Therapy meeting, Shaun Samuels, MD, met with his colleagues from the Baptist Cardiac & Vascular Institute in Miami, Florida, to discuss offering a symposium that...
Six years ago, at the conclusion of the International Symposium on Endovascular Therapy meeting, Shaun Samuels, MD, met with his colleagues from the Baptist Cardiac & Vascular Institute in Miami, Florida, to discuss offering a symposium that...
Six years ago, at the conclusion...
12/18/2013
IO Learning
Clinical Insights
01/03/2016
Arschang Valipour, MD, is a chest physician and intensivist at the Otto-Wagner-Spital Department of Respiratory and Critical Care Medicine in Vienna, Austria, as well as associate professor at Medical University of Vienna. He began using the...
Arschang Valipour, MD, is a chest physician and intensivist at the Otto-Wagner-Spital Department of Respiratory and Critical Care Medicine in Vienna, Austria, as well as associate professor at Medical University of Vienna. He began using the...
Arschang Valipour, MD, is a...
01/03/2016
IO Learning
Interview
07/01/2015
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular...
07/01/2015
Vascular Disease Management
Clinical Insights
11/26/2014
Older patients are often considered high-risk patients for medical procedures. Interventional oncology clinicians sought to answer the question: is transarterial chemoembolization (TACE) as safe and effective for elderly patients as it is for...
Older patients are often considered high-risk patients for medical procedures. Interventional oncology clinicians sought to answer the question: is transarterial chemoembolization (TACE) as safe and effective for elderly patients as it is for...
Older patients are often...
11/26/2014
IO Learning